For the first time since 2007, the National Heart Lung and Blood Institute (NHLBI) has updated the asthma management guidelines for clinicians and their patients.
The 2020 Focused Updates to the Asthma Management Guidelines, which are meant to complement — not replace — existing guidelines, include 19 recommendations covering six key areas:
- Fractional exhaled nitric oxide (FeNO) in diagnosis, medication selection and monitoring of treatment response in asthma
- Remediation of indoor allergens, such as dust and pet dander, in asthma management
- Use of a single combination medication to both prevent and treat symptoms
- Long-acting antimuscarinic agents in asthma management as add-ons to inhaled corticosteroids
- Immunotherapy and the management of asthma
- Bronchial thermoplasty (BT) in adult severe asthma
The NHLBI honed in on these specific areas to reflect the latest evidence-based clinical research as well as the promising new asthma treatments that have emerged in recent years.
At Propeller, we’re always keeping track of changes to respiratory care standards and their implications for digital health platforms like ours. We’re now investigating ways to modify the Propeller platform to better accommodate both patients and clinicians in accordance with the new guidelines.
To learn more about the guidelines and what they mean for you and your patients, sign up for our webinar on Tuesday, Feb. 9 at 11:00 am PT / 2 pm ET. David Stempel, MD, an allergist and former global medical lead at GlaxoSmithKline, will discuss the new guidelines and answer audience questions live.